BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
279 hedge funds and large institutions have $5.14B invested in Blueprint Medicines in 2021 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 108 increasing their positions, 72 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
10% less capital invested
Capital invested by funds: $5.69B → $5.14B (-$550M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
39% less call options, than puts
Call options by funds: $8.99M | Put options by funds: $14.8M
Holders
279
Holding in Top 10
5
Calls
$8.99M
Puts
$14.8M
Top Buyers
| 1 | +$59.9M | |
| 2 | +$41.6M | |
| 3 | +$37.8M | |
| 4 |
CCM
Cadian Capital Management
New York
|
+$35.9M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$28M |
Top Sellers
| 1 | -$263M | |
| 2 | -$106M | |
| 3 | -$31.9M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$20.7M |
| 5 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$10.9M |